[1]
Sutcu, H., Varol, G.F. , Inan, C., Uzun, I. and Sayin, N. 2022. Early Serum Heme Oxygenase-1, Soluble Vascular Endothelial Growth Factor Receptor-1, and B-Cell Lymphoma/Leukemia-2 Levels and Unfavorable Obstetric Outcomes. Gynecology Obstetrics & Reproductive Medicine. 28, 2 (Aug. 2022), 122–128. DOI:https://doi.org/10.21613/GORM.2021.1177.